Impact of MGMT Promoter Methylation Status on Tumor Dynamics during Weekly Adaptive Radiotherapy for Glioblastoma

被引：0
|
作者：
Hudson, J. M. [1 ]
Stewart, J. [2 ]
Zeng, K. L. [1 ]
Chen, H. [1 ]
Ruschin, M. E. [2 ]
Soliman, H. [1 ]
Tseng, C. L. [1 ]
Myrehaug, S. D. [1 ]
Husain, Z. A. [1 ]
Sahgal, A. [1 ]
Detsky, J. [1 ]
机构：
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, Odette Canc Ctr, Toronto, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
210
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [21] The influence of methylation status on a stochastic model of MGMT dynamics in glioblastoma: Phenotypic selection can occur with and without a downshift in promoter methylation status
    Lasri, Ayoub
    Sturrock, Marc
    [J]. JOURNAL OF THEORETICAL BIOLOGY, 2021, 521
  • [22] Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
    Tunthanathip, Thara
    Sangkhathat, Surasak
    Tanvejsilp, Pimwara
    Kanjanapradit, Kanet
    [J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2021, 12 (04) : 694 - 703
  • [23] MGMT promoter methylation in Peruvian patients with glioblastoma
    Belmar-Lopez, Carolina
    Castaneda, Carlos A.
    Castillo, Miluska
    Garcia-Corrochano, Pamela
    Orrego, Enrique
    Melendez, Barbara
    Casavilca, Sandro
    Flores, Claudio
    Orrego, Enrique
    [J]. ECANCERMEDICALSCIENCE, 2018, 12
  • [24] Utilization of MGMT Promoter Methylation Status to Guide Treatment in Elderly Patients With Glioblastoma
    Chu, Tiffany
    Wang, Ting
    Silberstein, Peter
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (06)
  • [25] Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma
    Uno, Miyuki
    Oba-Shinjo, Sueli Mieko
    Camargo, Anamaria Aranha
    Moura, Ricardo Pereira
    de Aguiar, Paulo Henrique
    Cabrera, Hector Navarro
    Begnami, Marcos
    Rosemberg, Sergio
    Teixeira, Manoel Jacobsen
    Nagahashi Marie, Suely Kazue
    [J]. CLINICS, 2011, 66 (10) : 1747 - 1755
  • [26] Quantitative analysis of MGMT promoter methylation status changes by pyrosequencing in recurrent glioblastoma
    Gonzalez Jimenez, Victor
    Brell Doval, Marta
    Gomez Bellvert, Cristina
    Goliney Goliney, Victor
    Salazar Asencio, Osman
    Gomez Martin, Adriana
    Ibanez Dominguez, Javier
    [J]. NEUROPATHOLOGY, 2023, 43 (04) : 306 - 312
  • [27] Influence of Intratumor Heterogeneity on the Predictivity of MGMT Gene Promoter Methylation Status in Glioblastoma
    Brigliadori, Giovanni
    Goffredo, Giulia
    Bartolini, Daniela
    Tosatto, Luigino
    Gurrieri, Lorena
    Mercatali, Laura
    Ibrahim, Toni
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [28] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Consolación Melguizo
    Jose Prados
    Beatriz González
    Raul Ortiz
    Angel Concha
    Pablo Juan Alvarez
    Roberto Madeddu
    Gloria Perazzoli
    Jaime Antonio Oliver
    Rodrigo López
    Fernando Rodríguez-Serrano
    Antonia Aránega
    [J]. Journal of Translational Medicine, 10
  • [29] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Melguizo, Consolacion
    Prados, Jose
    Gonzalez, Beatriz
    Ortiz, Raul
    Concha, Angel
    Juan Alvarez, Pablo
    Madeddu, Roberto
    Perazzoli, Gloria
    Antonio Oliver, Jaime
    Lopez, Rodrigo
    Rodriguez-Serrano, Fernando
    Aranega, Antonia
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [30] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Gonzalez-Astorga, B.
    Luque, R.
    Castellon, V.
    Gonzalez, E.
    Sanchez, C.
    Soberino, J.
    Gonzalez, C.
    Ruiz, J.
    Zurita, M.
    Delgado, J. R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S794 - S794
12345